Starling Oncology (STLNW) EBIT Growth (1y) (2021 - 2026)
Powered by 
Analysis
Starling Oncology (STLNW) EBIT Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | 7.65% |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | 27.82% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 12.48% |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | 28.51% |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | 252.91% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | -4.92% |
| 7 | Progyny | 2.12 Bn | 1.89 Bn | 89.30 Mn | 64.23% |
| 8 | Surgery Partners | 1.82 Bn | 1.61 Bn | 622.10 Mn | -8.59% |
| 9 | U S Physical Therapy | 1.17 Bn | 1.14 Bn | 41.94 Mn | -12.00% |
| 10 | Starling Oncology | 4.13 Mn | -36.96 Mn | 27.17 Mn | 58.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 58.83% |
| Mar 31, 2026 | 34.29% |
| Dec 31, 2025 | 42.10% |
| Sep 30, 2025 | 41.86% |
| Jun 30, 2025 | 31.49% |
| Mar 31, 2025 | 44.85% |
| Dec 31, 2024 | 21.97% |
| Sep 30, 2024 | 0.52% |
| Jun 30, 2024 | -9.55% |
| Mar 31, 2024 | 45.32% |
| Dec 31, 2023 | 39.04% |
| Sep 30, 2023 | 30.71% |
| Jun 30, 2023 | 18.39% |
| Mar 31, 2023 | -77.94% |
| Dec 31, 2022 | 38.58% |
| Sep 30, 2022 | -831.71% |
| Jun 30, 2022 | -1,540.14% |
| Mar 31, 2022 | -953.68% |
| Dec 31, 2021 | -429.17% |
| Sep 30, 2021 | -986.76% |